Skip to main content
VIVOZON PHARMACEUTICAL CO., LTD. logo

VIVOZON PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 082800 ISIN · KR7082800004 KO Manufacturing
Filings indexed 590 across all filing types
Latest filing 2019-03-21 Declaration of Voting R…
Country KR South Korea
Listing KO 082800

About VIVOZON PHARMACEUTICAL CO., LTD.

https://www.vivozon.com/

VIVOZON PHARMACEUTICAL CO., LTD. is a research and development company specializing in the discovery and commercialization of innovative drugs, with a primary focus on pain and central nervous system (CNS) diseases. The company utilizes a multi-target drug development platform to create new chemical entities that act on multiple targets to achieve synergistic efficacy. This approach integrates efficacy-based screening from the early stages of discovery to identify candidate substances with a high potential for successful clinical development. Its lead pipeline candidate is Opiranserin (VVZ-149), a first-in-class, non-narcotic injectable analgesic for post-operative pain management. The company is actively expanding its pipeline to address a broader range of unmet medical needs within the CNS field.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, director/auditor appointments, and remuneration limits. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA), as it reports the official outcomes of shareholder votes at an AGM.
2019-03-21 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the resignation of an outside director (이장원) from Lumimicro Co., Ltd. This type of disclosure regarding changes in board composition falls under the 'Board/Management Information' category.
2019-03-21 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment of an outside director (사외이사). It details the name of the director, their term, and their professional background. This falls under the category of board or management changes.
2019-03-21 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by Lumimicro. It contains the auditor's opinion, key financial data, and details regarding the audit process. While it provides financial summaries, it is a specific regulatory filing announcing the completion and submission of the audit report to the exchange, rather than the full annual report (10-K) or a simple publication announcement (RPA). Given the specific nature of audit report filings in the Korean regulatory context (DART/KIND), it falls under the Audit Report/Information category. FY 2018
2019-03-13 Korean
조회공시요구(풍문또는보도)에대한답변(미확정)
Regulatory Filings Classification · 95% confidence The document is a formal response to a regulatory inquiry (조회공시요구) regarding rumors of a merger (합병 추진설) between Lumni Micro and Dainona Co., Ltd. It provides an update on the status of the merger, stating it is still under review and not yet finalized. Since this is a regulatory disclosure regarding corporate activity (merger rumors) and does not fit into specific categories like M&A finalization or financial reporting, it is classified as a general regulatory filing.
2019-03-11 Korean
주주총회소집공고
AGM Information Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Lumimicro Co., Ltd. It contains the meeting agenda, details on voting rights, director activity reports, and management information. This type of document is standard for providing shareholders with the necessary information to vote at an upcoming AGM. According to the filing definitions, materials shared for an AGM are classified as AGM-R.
2019-03-06 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.